MMP9 and keratoconus: In addition, in vivo evaluation of protein expression of matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9) using IHC and their gene expression using qPCR in KC tumors revealed a decreased expression of these enzymes in ferrichrome-treated tumors as compared to vehicle-treated tumors (Fig. 4d, e).